161 related articles for article (PubMed ID: 37679788)
1. ESRRG-PKM2 axis reprograms metabolism to suppress esophageal squamous carcinoma progression and enhance anti-PD-1 therapy efficacy.
Wang T; Zhu Y; Chen L; Zhang W; Qi H; Shi X; Zhong M; Chen H; Li Q
J Transl Med; 2023 Sep; 21(1):605. PubMed ID: 37679788
[TBL] [Abstract][Full Text] [Related]
2. The mTOR Pathway Regulates PKM2 to Affect Glycolysis in Esophageal Squamous Cell Carcinoma.
Xiaoyu H; Yiru Y; Shuisheng S; Keyan C; Zixing Y; Shanglin C; Yuan W; Dongming C; Wangliang Z; Xudong B; Jie M
Technol Cancer Res Treat; 2018 Jan; 17():1533033818780063. PubMed ID: 29916308
[TBL] [Abstract][Full Text] [Related]
3. circCYP24A1 facilitates esophageal squamous cell carcinoma progression through binding PKM2 to regulate NF-κB-induced CCL5 secretion.
Gu L; Sang Y; Nan X; Zheng Y; Liu F; Meng L; Sang M; Shan B
Mol Cancer; 2022 Dec; 21(1):217. PubMed ID: 36514094
[TBL] [Abstract][Full Text] [Related]
4. Dihydroartemisinin mediating PKM2-caspase-8/3-GSDME axis for pyroptosis in esophageal squamous cell carcinoma.
Jiang M; Wu Y; Qi L; Li L; Song D; Gan J; Li Y; Ling X; Song C
Chem Biol Interact; 2021 Dec; 350():109704. PubMed ID: 34655567
[TBL] [Abstract][Full Text] [Related]
5. Alterations in glucose metabolism proteins responsible for the Warburg effect in esophageal squamous cell carcinoma.
de Andrade Barreto E; de Souza Santos PT; Bergmann A; de Oliveira IM; Wernersbach Pinto L; Blanco T; Rossini A; Pinto Kruel CD; Mattos Albano R; Ribeiro Pinto LF
Exp Mol Pathol; 2016 Aug; 101(1):66-73. PubMed ID: 27260309
[TBL] [Abstract][Full Text] [Related]
6. Nuclear PKM2 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Zhang X; He C; He C; Chen B; Liu Y; Kong M; Wang C; Lin L; Dong Y; Sheng H
Pathol Res Pract; 2013 Aug; 209(8):510-5. PubMed ID: 23880164
[TBL] [Abstract][Full Text] [Related]
7. Metabolic remodeling by TIGAR overexpression is a therapeutic target in esophageal squamous-cell carcinoma.
Chu J; Niu X; Chang J; Shao M; Peng L; Xi Y; Lin A; Wang C; Cui Q; Luo Y; Fan W; Chen Y; Sun Y; Guo W; Tan W; Lin D; Wu C
Theranostics; 2020; 10(8):3488-3502. PubMed ID: 32206103
[No Abstract] [Full Text] [Related]
8. SUMOylation of HSP27 regulates PKM2 to promote esophageal squamous cell carcinoma progression.
Zhang X; Liu T; Zheng S; Liu Q; Shen T; Han X; Zhang Q; Yang L; Lu X
Oncol Rep; 2020 Oct; 44(4):1355-1364. PubMed ID: 32945483
[TBL] [Abstract][Full Text] [Related]
9. Dihydroartemisinin represses esophageal cancer glycolysis by down-regulating pyruvate kinase M2.
Li S; Huang P; Gan J; Ling X; Du X; Liao Y; Li L; Meng Y; Li Y; Bai Y
Eur J Pharmacol; 2019 Jul; 854():232-239. PubMed ID: 31004604
[TBL] [Abstract][Full Text] [Related]
10. PDK1 regulates the progression of esophageal squamous cell carcinoma through metabolic reprogramming.
Ma Y; Zhang X; Han X; Hao Z; Ji R; Li J; Guo W; Zhang Y; Guan F; Ma S
Mol Carcinog; 2023 Jun; 62(6):866-881. PubMed ID: 36988347
[TBL] [Abstract][Full Text] [Related]
11. M2 isoform of pyruvate kinase (PKM2) is upregulated in Kazakh's ESCC and promotes proliferation and migration of ESCC cells.
Liu Q; Liang M; Liu T; Vuitton L; Zheng S; Gao X; Lu M; Li X; Sheyhidin I; Lu X
Tumour Biol; 2016 Feb; 37(2):2665-72. PubMed ID: 26404132
[TBL] [Abstract][Full Text] [Related]
12. Plasma‑derived exosomal pyruvate kinase isoenzyme type M2 accelerates the proliferation and motility of oesophageal squamous cell carcinoma cells.
Yang L; Zheng S; Liu Q; Liu T; Zhang Q; Han X; Tuerxun A; Lu X
Oncol Rep; 2021 Oct; 46(4):. PubMed ID: 34396437
[TBL] [Abstract][Full Text] [Related]
13. Shikonin Inhibits Tumor Growth of ESCC by suppressing PKM2 mediated Aerobic Glycolysis and STAT3 Phosphorylation.
Zhang Q; Liu Q; Zheng S; Liu T; Yang L; Han X; Lu X
J Cancer; 2021; 12(16):4830-4840. PubMed ID: 34234853
[No Abstract] [Full Text] [Related]
14. Nicotinamide N-methyltransferase decreases 5-fluorouracil sensitivity in human esophageal squamous cell carcinoma through metabolic reprogramming and promoting the Warburg effect.
Cui Y; Yang D; Wang W; Zhang L; Liu H; Ma S; Guo W; Yao M; Zhang K; Li W; Zhang Y; Guan F
Mol Carcinog; 2020 Aug; 59(8):940-954. PubMed ID: 32367570
[TBL] [Abstract][Full Text] [Related]
15. CCT4 knockdown enhances the sensitivity of cisplatin by inhibiting glycolysis in human esophageal squamous cell carcinomas.
Fang J; Ma Y; Li Y; Li J; Zhang X; Han X; Ma S; Guan F
Mol Carcinog; 2022 Nov; 61(11):1043-1055. PubMed ID: 36102200
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance and function of the vacuolar H+-ATPase subunit V1E1 in esophageal squamous cell carcinoma.
Son SW; Kim SH; Moon EY; Kim DH; Pyo S; Um SH
Oncotarget; 2016 Aug; 7(31):49334-49348. PubMed ID: 27384996
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy induces human esophageal carcinoma cell pyroptosis by targeting the PKM2/caspase-8/caspase-3/GSDME axis.
Li L; Song D; Qi L; Jiang M; Wu Y; Gan J; Cao K; Li Y; Bai Y; Zheng T
Cancer Lett; 2021 Nov; 520():143-159. PubMed ID: 34256094
[TBL] [Abstract][Full Text] [Related]
18. Pyruvate kinase M2 is highly correlated with the differentiation and the prognosis of esophageal squamous cell cancer.
Zhan C; Shi Y; Lu C; Wang Q
Dis Esophagus; 2013; 26(7):746-53. PubMed ID: 23317289
[TBL] [Abstract][Full Text] [Related]
19. Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus.
Fu J; Xiong Z; Huang C; Li J; Yang W; Han Y; Paiboonrungruan C; Major MB; Chen KN; Kang X; Chen X
J Biol Chem; 2019 Jan; 294(1):327-340. PubMed ID: 30409900
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
Cheng J; Zhang R; Yan M; Li Y
BMC Cancer; 2022 Mar; 22(1):238. PubMed ID: 35241028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
